Sorafenib, Cisplatin, and Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer

This study has been terminated.
(Extreme toxicity)
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Afshin Dowlati, MD, Case Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT00726986
First received: July 31, 2008
Last updated: April 17, 2013
Last verified: February 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2012
  Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)